WHAT'S INSIDE
 Harnessing our Collective Power | WuXi Online Forum II on COVID-19
New Innovative Solution | Magic Power of Quantum Mechanics
Upcoming Webinar | Target to Hit Finding: New Methods in Fragment-Based Drug Discovery
Resources | CRISPR Library Screen to Identify Driver Mutations of Tumor Growth and Metastasis
Innovation that Matters | BIO’s COVID-19 Lead George Scangos: The Call to Action
 Forum panelists addressed this defining moment in history and its impact on the biotech industry. They discussed lessons learned since the outbreak, the development of diagnostic approaches, and the prospects for therapeutic interventions and a vaccine in the near future.

To Empower Organic Syntheses

Would you like to predict organic reaction outcomes accurately? How about designing synthetic sequences with higher rates of success and learn and rationalize organic chemistry in a data-driven manner?
I n this webinar, Dr.habil. Nuska Tschammer will present advanced technologies available for the target-to-hit developmental stage of the drug discovery process. Successful solutions integrate multiple aspects, including target acquisition, hit identification, and comprehensive characterization of hit series, including a dissection of mechanism of action (MoA) by using state-of-the art structural biology approaches.
Attend to learn:
  • Advantages and limitations of fragment based drug discovery
  • The importance of protein quality and protein construct for a successful screening campaign
  • Fragment-to-hit optimization processes: structure or function enabled
On-demand WEBINAR
Watch this webinar to review case studies highlighting the application of customized CRISPR/Cas9 libraries to screen for genes controlling cancer cell sensitivity to target therapeutic agents as well as T cell-mediated elimination both in vitro and in vivo. These genes are potential targets for therapeutic intervention.
George Scangos was appointed by BIO, biotech’s largest industry trade group, to lead the battle against COVID-19. Dr. Scangos will help BIO in its efforts to accelerate therapeutics, vaccines and diagnostics as scientists, public health experts, and policy makers seek to contain and mitigate the spread of the virus.